{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:20:04Z","timestamp":1793409604916,"version":"4.5.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1097\/cad.0000000000000084","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T09:35:10Z","timestamp":1390556110000},"page":"624-632","source":"Crossref","is-referenced-by-count":27,"title":["EAPB0503, a novel imidazoquinoxaline derivative, inhibits growth and induces apoptosis in chronic myeloid leukemia cells"],"prefix":"10.1097","volume":"25","author":[{"given":"Jessica","family":"Saliba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Deleuze-Masqu\u00e9fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Iskandarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabab","family":"El Eit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed","family":"Hmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Xavier","family":"Mahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Antoine","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihab","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210203","first-page":"724360","article-title":"Emerging therapeutic strategies for targeting chronic myeloid leukemia stem cells.","volume":"2013","author":"Hamad","year":"2013","journal-title":"Stem Cell Int"},{"key":"R2-3-20210203","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1172\/JCI41246","article-title":"Chronic myeloid leukemia: mechanisms of blastic transformation.","volume":"120","author":"Perrotti","year":"2010","journal-title":"J Clin Invest"},{"key":"R3-3-20210203","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-4614-6176-0_8","article-title":"Tyrosine kinase targeted treatment of chronic myelogenous leukemia and other myeloproliferative neoplasms.","volume":"779","author":"Bisen","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"R4-3-20210203","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.patbio.2012.05.010","article-title":"Chronic myeloid leukemia: archetype of the impact of targeted therapies.","volume":"60","author":"Nasr","year":"2012","journal-title":"Pathol Biol (Paris)"},{"key":"R5-3-20210203","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11912-012-0253-9","article-title":"Chronic myeloid leukemia: state of the art in 2012.","volume":"14","author":"Fava","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"R6-3-20210203","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.biocel.2007.10.001","article-title":"Overcoming kinase resistance in chronic myeloid leukemia.","volume":"40","author":"Lee","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"R10-3-20210203","first-page":"268","article-title":"Imiquimod (Aldara): modifying the immune response.","volume":"14","author":"Rudy","year":"2002","journal-title":"Dermatol Nurs"},{"key":"R11-3-20210203","first-page":"555","article-title":"Topical imiquimod treatment of a cutaneous melanoma metastasis.","volume":"43","author":"Steinmann","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R13-3-20210203","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1423-0127-17-32","article-title":"Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination.","volume":"17","author":"Chuang","year":"2010","journal-title":"J Biomed Sci"},{"key":"R21-3-20210203","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method.","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"R22-3-20210203","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1038\/sj.onc.1204326","article-title":"Histone H3 phosphorylation and cell division.","volume":"20","author":"Hans","year":"2001","journal-title":"Oncogene"},{"key":"R23-3-20210203","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.cb.04.110188.001103","article-title":"Mitochondrial membrane potential in living cells.","volume":"4","author":"Chen","year":"1988","journal-title":"Annu Rev Cell Biol"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0000000000000084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:01:44Z","timestamp":1620946904000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201407000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0000000000000084","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}